chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Feb2021 at 11:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 70 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Arrhythmia" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of covid-19. Clinical course: On 19May2022, started anti-viral covid-19 treatment (paxlovid), (lot number: FY8932) and treatment stop on 22May2022, for treatment of covid-19. On 18May2022, patient had other medication in 2 weeks with day quilt night quil (lot number: 2ak1093) and product stop on 20May2022. The patient experienced metallic taste starting day 3 Diarrhea for first 2 days with onset 19May2022 at 01:00 PM, outcome "not recovered" and had not adverse event treatment. Patient had no known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200743797 Same pt, diff event/drug
Patient presented to the ED and was subsequently hospitalized for suicide attempt within 6 weeks of receiving covid vaccination.
Hospital Course:  The patient was admitted with right sided weakness. She was found to have a Left parital CVA. She was also found to have COVID 19. The patient was not hypoxic and did not get treated for the Covid 19. She also had persistant afib. She was not able to swallow so she was maintained on a amiodarone gtt. She had an elevated D.dimer. CTA of the chest did not show a PE but she was found to have bilateral lower extremity DVT's. In speaking with the patient and her daughter they did not want any further testing or procedures done. The patient wanted to go home. The daughter, who is in her 70's, was not able to take care of all her needs so they decided on comforte care and wished to go to inpatient hospice. The patinet was not able to swallow her meds. I told the daughter an the pt that if we do comforte care I can let her eat but she needs to understand that her risk of aspiration is high. She voiced understanding and wished to go with comfortae care. I will let the patient eat.    Consults to:  Neurology, cardiology.    Significant Diagnostic Studies:  CT head, CTA chest, CTA head and neck. MRI brain. 2d echo.    Procedure(s): none.    Disposition:Home with hospice.    Discharge Condition:  Poor.
evening of 6NOV93 exp low grade fever & chills; felt real bad; On evening of 7NOV93 noticed edema, tenderness & erythema of medial surface rt forearm just below elbow; tender, red edematous & cool to touch;
Pt broke out with chicken pox after exposure to cousins. No fever. ~50 lesions over entire body-more concentrated groin area. Itchy and red lesions, have crusted over. No wheezing.
Started w/pain at injection site kept waking me up during the night. Day 2- Arm stiffened up, injection site was very warm, unable to raise it above my breast area, constant ache, mild headache, nausea. Day 3- Woke w/a large red welt/swollen patch approximately 3" x 3", 3 smaller welts lengthwise around the injection site, hot to the touch, major headache, slight nausea, barely sleeping from pain.
pt recv vax 28AUG97 & 17JUN97 pt devel a mild varicella rash consisting of approx 10 lesions on torso & devel a low grade fever p/an exposure @ school;pt recovered;
A non-serious spontaneous report of administration to patient with thyroid disease was received from a pharmacist concerning a 33-year-old female. Medical history included thyroid disease. No concomitant medications had been reported for this patient. On 20-Oct-2011, the patient received FLUMIST. The reporter stated that she did not realize that the patient's medical history included thyroid disease. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
The County Office of Public Health Received a shipment of Moderna Covid-19 vaccine on Wednesday, January 27th. It was immediately put into refrigerated storage. The refrigerator unit is monitored using a DDL and attached to an alarm system so that staff are quickly notified of temperature excursions.  At 7:30 the next morning 1200 doses of vaccine were removed for administration at a mass vaccination clinic. At 8:25 100 doses were removed from the prepared Credo cooler and allowed to come to room temperature for no less than 15 minutes. The 6 vials were distributed to vaccination stations where nurses began to draw up vaccine. One nurse noticed that her vaccine was not entirely thawed. All other vials were inspected and two others were found to be partially frozen as well. It was also discovered that one of the pre-drawn doses had been administered to subject of this report. The patient was monitored for approximately one hour, while the staff consulted moderna and medical staff about the safety and validity of the dose administered. No adverse signs or symptoms were noted during that time.
Full body rash, itchy, pins and needle feeling all over the body. Some joint pain. Noticed the day after the second shot. Got progressively worse over the next day. I Saw PCP Doctor Friday and Dermatologist On Monday. The treatment has been bed rest, 4mg MethlPREDNISolone and Clobetasol 0.05%. Some of the rash is clearing up.
losing her hair/I'll practically be bald headed in a little bit; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (losing her hair/I'll practically be bald headed in a little bit) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21-2A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 12-Nov-2020. Concomitant products included COLECALCIFEROL (VITAMIN D3) for Vitamin D deficiency, TORSEMIDE, LISINOPRIL, AMLODIPINE BESYLATE and ATORVASTATIN for an unknown indication.    On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (losing her hair/I'll practically be bald headed in a little bit). At the time of the report, ALOPECIA (losing her hair/I'll practically be bald headed in a little bit) outcome was unknown.
Injection site was red and swollen the size of an orange and hot and tender to touch. It also itches and "bothers him".
No adverse reaction to vaccine. Came down with Covid a little more than two months later, on 7/3/2022.
A sensitivity in the skin around my torso from just under my breasts to roughly 4 inches below that. More sensitive in the front. Equal on both sides. The sensation reminds me of the sensitivity my skin feels when I have the flu. Pain level on a scale from 1 - 10 is 3. No really painful, just annoying and always present.
My symptoms began with a sore throat. I took a home COVID-19 test and it was negative. I had cold symptoms. I continued to have symptoms and tested positive on June 18, 2023. I had runny nose, cough and mild congestion.
I experienced drooping eye lid and double vision in Mar23 and I was diagnosed with Myasthenia gravis. I saw my eye doctor on 13MAR23. The bloodwork showed this diagnosis after 10 days. I am doing a follow up the doctor in May23.
This spontaneous report as received from a pharmacist refers to a 26 year old Adult female patient. Patient had no pertinent medical history, drug allergies or reactions and concomitant medication. On 30-OCT-2018, the patient was vaccinated with VARIVAX lot # R011806, expiration date: 23-APR-2020, in the left arm for prophylaxis. Other suspect therapies included BOOSTRIX and sterile diluent. On 30-OCT-2018, the patient experienced itching all over, cold and flu symptoms, fever, headache and numbness in her left arm (pyrexia, hypoaesthesia, nasopharyngitis, influenza like illness and pruritus generalized). On 02-NOV-2018. Patient sought medical attention from pharmacist and reported that the patient was still experiencing headache, pruritus generalised, pyrexia, hypoaesthesia, nasopharyngitis and influenza like illness and instructed her to take unspecified doses of TYLENOL and BENADRYL as needed to heal events. No laboratory diagnostics were performed. The outcome of the event was as not resolved. The causality assessment between itching all over, cold and flu symptoms, fever, headache and numbness in her left arm and VARIVAX was not provided.
PATIENT NOTICE SOME BLEEDING UNDER THE BARRIER BAND-AID THAT PHARMACY USED DURING THE INJECTION. SHE REPLACE IT WITH NEW BAND-AID. SOON AFTER, SHE NOTICE A DIME-SIZED BLISTER AT INJECTION SITE. SHE EXPERIENCE SOME ITCHINESS. SHE SOUGHT MEDICAL ADVICE AT EMERGENCY ROOM SINCE HER PRIMARY CARE PHYSICIAN WAS NOT AVAILABLE. DOCTOR EXPLAINED TO PATIENT THE BLISTER IS MOST LIKELY FROM THE INJECTION AND TO LET IT POP ON ITS OWN. NO MEDICATION WAS NECESSARY.
Cae number PHHY2014US159804, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 545659) website on 28 Nov 2014. This report refers to a 61-year-old male patient. He was vaccinated with Seasonal Influenza vaccine (manufacturer and batch number: not reported) on 26 Sep 2014. On the same date, after vaccination he experienced complete loss of sense of taste, severe muscle soreness and headaches. The outcome of the events reported as not recovered. The events reported as non-serious. The causality of the events was not reported.
A little over 24 hours after my Covid Moderna booster, I became very ill. Low grade fever, horrendous body aches, major exhaustion, and sore throat. This has lasted for 96 hours. Peaking around 48 hours, far less by 96 hours.
Severe left shoulder joint pain; Severe left shoulder joint pain and arm pain in that area; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 24Apr2021 at 13:15 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included degenerative disc disease and herniated discs. The patient was allergic to penicillin and bee stings. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included celecoxib (CELEBREX), atorvastatin calcium (LIPITOR), hydrocodone bitartrate, paracetamol (NORCO), morphine sulfate (MORPHINE SULF) and cyclobenzaprine hydrochloride (FLEXERIL); all taken for an unspecified indication from an unknown date and unknown if ongoing. On 25Apr2021 at 00:00, the patient experienced severe left shoulder joint pain and arm pain in that area. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe left shoulder joint pain and arm pain in that area was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Severe left side stomach pains that started around 4am continued to get worse until going to Emergency Room around 10 or 11am. Pain lasted several months, slowly subsiding over those months. As left side pain decreased, fatigue increased. Then all over muscle pains started at the end of August. Pain continued to increase over the next few months, along with general fatigue.
Fatigue, bruising and soreness at injection site, itchy hives on arm, hand and stomach, headache.
Information has been received from a registered nurse concerning a 14 year old female who on 08-OCT-2009 was vaccinated with her second 0.5mL dose of GARDASIL (route and lot number not reported). Concomitant therapy included FLUMIST. IT was reported that half an hour later, on 08-OCT-2009, the patient experienced passed out, hit her head and had a seizure. The patient was taken to the emergency room and was released. The physician felt it was important to note that the patient had not eaten prior to vaccination. The patient recovered from hit her head, passed out and seizure on the same day. Follow up information was received from a registered nurse concerning the 14 year old female patient with no pertinent medical history reported and no known drug allergies who on 08-OCT-2009 was vaccinated with her second dose of GARDASIL (lot number 663451/0216Y) and concomitantly with a dose of FLUMIST (lot number 500711P). The registered nurse reported that the patient left the office and was in a restaurant when she "passed out and stiffened" on 08-OCT-2009. The patient was taken to the ER where a CT of the head, EKG, chest X-ray and blood work were performed (all normal). No treatment was needed. It was noted that the patient received the first dose of GARDASIL (route not reported, lot number 664780/0904Y, valid for ROTATEQ) on 16-JUL-2009. Upon internal review, seizure was determined to be an other important medical event. Additional information has been requested.
Severe fatigue onset at 11:00AM 1/28/2021. Onset of chills and myalgias progressively that have continued as of this writing on 02/02/2021. Intermittent Chills continue and severe fatigue continues at this writing. Max temp was 99.4F
COVID-19; COVID-19; one vaccination is from Moderna and 2 from Pfizer; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in 2021 as dose number unknown, single (Batch/Lot number: unknown) and in 2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), in 2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 2021, outcome "unknown", described as "one vaccination is from Moderna and 2 from Pfizer"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "COVID-19".  Clinical course:  It was reported that the patient had an AE of COVID-19 with previous Pfizer COVID vaccinations. Vaccination Dates included 27Feb2021, 20Mar2021, 28Dec2021. The reporter was informed that one vaccination is from Moderna and 2 from Pfizer. The reporter do not know which vaccines correspond to which dates. Lot numbers were reported as unknown. COVID-19 AE was reported 05Dec2022 to 18Dec2022. Confirmation via a test was not provided. This occurred at a site.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Complaining of acute onset photosensitivity, body aches, nausea, and one episode of vomiting and tingling around his lips and mouth. No signs or symptoms of hives or swelling at site. No complaints of difficulty breathing or dizziness. Patient refused administration of epinephrine or calling emergency.
On day one of injection experienced mild soreness.  Days 2-4 developed red, warm, swollen and very sore area at injection site (circular sized of tennis ball).  This went away after day 4.  Eight days after vaccination, itching started at injection site.  Next morning hard, red tennis ball sized area reoccurred  with increased itching.  This is day 12 since vaccination and redness and itching has not decreased. Have not sought medical treatment, as this reaction as described appears on internet sources as "Covid Arm" and not serious.
I am reporting in case this could be related.  Very rare fast growing sarcoma identified after a CT scan for another issue.  It grew to 8 cm in a matter of months.
horrible reactions/If they had been frail it would have killed them; This case was reported by a consumer via interactive digital media and described the occurrence of adverse reaction in an unknown number of patients who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and PNEUMOCOCCAL VACCINE (PNEUMONIA VACCINE) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season, Shingles vaccine and PNEUMONIA VACCINE. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season and Shingles vaccine, the patient experienced adverse reaction (serious criteria life threatening). On an unknown date, the outcome of the adverse reaction was unknown.   The reporter considered the adverse reaction to be related to Influenza vaccine Quadrivalent unspecified season and Shingles vaccine.  Additional details were provided as follows: Age at vaccination was not reported applicable for this report. The reporter stated stop pushing death. The patients had horrible reactions from the flu, pneumonia and shingles vaccination. If they had been frail it would have killed them.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR189605:same reporter
Moderna COVID-19 Vaccine EUA  Generalized external itching throughout entire body with no obvious rash involved. Symptom began approximately one day following vaccine administration and have continued until present day, so far now for 5 days. Have not taken any medications thus far but will try Benadryl today.
13 hours after 2nd shot administered developed body aches and chills with slight headache.  Lasted till 6 PM 4/4/2021.  Slept well thru the night and felt fine the next morning.
Information was received from a lawyer regarding a case in litigation involving a female patient, age and medical history not provided. In 2015 the patient was inoculated with ZOSTAVAX vaccine at a pharmacy for routine adult health maintenance and the prevention of shingles. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster or shingles. On or about 02-JUL-2015 the patient was treated at a hospital for onset of severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX or despite receiving ZOSTAVAX for prevention of shingles, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain, suffering and other damages. Additional information has been requested.
3rd after 1st series Pediarix/PVH/Prevnar had cry out, stiff, foamed at mouth, and then slept for a while.
No adverse event; Nurse reporting that immunization coordinator informed that a Moderna Monovalent dose was administered today 23Feb2023 to a 4 year old patient after date of expiry on 21Feb2023.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Nurse reporting that immunization coordinator informed that a Moderna Monovalent dose was administered today 23Feb2023 to a 4 year old patient after date of expiry on 21Feb2023.) and NO ADVERSE EVENT (No adverse event) in a 4-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1420B) for COVID-19 prophylaxis.     Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 23-Feb-2023, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Feb-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Nurse reporting that immunization coordinator informed that a Moderna Monovalent dose was administered today 23Feb2023 to a 4 year old patient after date of expiry on 21Feb2023.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Nurse reporting that immunization coordinator informed that a Moderna Monovalent dose was administered today 23Feb2023 to a 4 year old patient after date of expiry on 21Feb2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Nurse reporting that immunization coordinator informed that a Moderna Monovalent dose was administered today 23Feb2023 to a 4 year old patient after date of expiry on 21Feb2023.).    No concomitant medications was provided. Individual vial was reported. Vial size was 2.5 mL the vial was initially stored in the refrigerator was on 1Feb2023  the vial did not undergo any temperature excursions.  No treatment medications was provided.
Prolonged pain the top left arm at shoulder socket. Feeling of paralysis radiating down arm into hands.
Taken from medical note: Called to immunizations clinic for pt w/hives/itching about 20-30 min after receiving flu shot, R arm, no prior hx of reaction, no other unusual foods/exposures today.  Pt talking and w/o distress, complaining of itching/burning at injection site and itching on back as well as some throat itching and heaviness in throat.  Benadryl po 10 ml (25 mg) given and Epipen 0.3 mg autoinjector given.  Initial vitals reassuring, Lungs CTAB.  Pt w/ hx of iron def anemia and hypertension, is on metoprolol and is compliant.   Pt w/ improvement of sxs however within a few min, no more throat heaviness, less itching.  VSS remaining normal w/ unexpected hypertension as epi was administered before it was known pt was on beta blocker.  Pt observed for 35-40 min w/ improvement, epi rx'd and f/u to ER if any further sxs.  Avoid flu shots in future unless under supervision of allergist.
Initial report received from a PharmD on 03 December 2010.  An 11-year-old male patient whose medical history was unknown, was hospitalized with Acute Disseminated  Encephalomyelitis 1 day after receiving a dose of MENACTRA (lot number unknown), DTAP (DTAP, also may have been TDAP but DTAP is recorded in the record, and trade name unknown), and VARICELLA vaccines on 16 November 2010.  The manufacturer name, lot number, route and site of administration was "unknown" for the DTAP and VARICELLA vaccines.  On 17 November 2010 the patient had symptoms and was hospitalized "20 days".  Recovery status was not reported.  No other medically relevant information was received.  Documents held by sender:  None.